Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Quality Alerts: FDA Issues Form 483 to Dr. Reddy's Laboratories - Dr. Reddy\'s Laboratories

Dr. Reddy's Laboratories

Uploaded: 2018

Safer Eyedrops May Need FDA Powers Amid Recalls

19 Dec 2024

// BUSINESS STD

Dr. Reddy’s launches Toripalimab under brand name Zytorvi in India

30 Nov 2024

// PRESS RELEASE

Senores Pharma Launches Ivermectin Tablets In US With Dr. Reddy’s

28 Nov 2024

// INDPHARMAPOST

DATA COMPILATION
#PharmaFlow

DRL

Contact Supplier

CPhI WW Frankfurt

Booth #9.1B48

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/cIxfnsaeBmc

Xls

CATEGORY PAGE

Dr. Reddy's Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, API Product List 2024, Products Under Development 2024, FDF Product List 2024, GMP Certificate 2024

Product List 2024
Corporate Presentation
API Product List 2024
Products Under Development 2024
FDF Product List 2024
GMP Certificate 2024

VIDEO(s)

Your Partner for High-Quality & Cost-effective APIs, Dr. Reddy's - About Us

Your Partner for High-Quality & Cost-effective APIs
Dr. Reddy's - About Us

DIGITAL CONTENT

1 VLOG #PharmaReel, 8 CORPORATE CONTENT #SupplierSpotlight, 5 DATA COMPILATION #PharmaFlow, 1076 NEWS #PharmaBuzz

1 VLOG #PharmaReel
8 CORPORATE CONTENT #SupplierSpotlight
5 DATA COMPILATION #PharmaFlow
1076 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

234 All APIs, 156 USDMF, 51 CEP/COS, 31 JDMF, 135 EU WC, 151 KDMF, 183 NDC API, 146 Listed APIs

234 All APIs
156 USDMF
51 CEP/COS
31 JDMF
135 EU WC
151 KDMF
183 NDC API
146 Listed APIs

DEVELOPMENTS

137 Drugs in Development

137 Drugs in Development

FINISHED DOSAGE FORMULATIONS

806 FDF Dossiers, 573 FDA Orange Book, 10 Europe, 223 Listed Dossiers

806 FDF Dossiers
573 FDA Orange Book
10 Europe
223 Listed Dossiers

KEY PRODUCTS

Capecitabine, Carfilzomib, Dabigatran Etexilate Mesylate, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Enzalutamide, Eribulin, Ferric Carboxymaltose, Iron Sucrose, Mirabegron, Nilotinib, Olaparib, Palbociclib, Quetiapine Hemifumarate, Rivaroxaban, Sacubitril-Valsartan, Sitagliptin Hydrochloride, Sitagliptin Malate, Sitagliptin Phosphate, Sugammadex Sodium

Capecitabine
Carfilzomib
Dabigatran Etexilate Mesylate
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Enzalutamide
Eribulin
Ferric Carboxymaltose
Iron Sucrose
Mirabegron
Nilotinib
Olaparib
Palbociclib
Quetiapine Hemifumarate
Rivaroxaban
Sacubitril-Valsartan
Sitagliptin Hydrochloride
Sitagliptin Malate
Sitagliptin Phosphate
Sugammadex Sodium

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

66 FDA, 37 EDQM, 18 GDUFA

66 FDA
37 EDQM
18 GDUFA

PC100302

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?